Your Trusted Partner in South America for EU-GMP
Cannabis Derived API and Products

About us

GreenMed is a Leading, Innovative,
End-to-End, Cannabis Processing Company

Based and fully licensed in Uruguay, GreenMed is a EU-GMP compliant laboratory in the South America’s Mercosur region. It was built to provide cannabis post-harvest processing, API’s formulation and product development based on customer and market needs.

Our Commitment

Strictest Pharmaceutical Standards are at the Core of our Processes

We are committed to consistently deliver Safe, High Quality and Standardized products which patients
and physicians can rely on.

Our Operations

We focus on end-to-end pharma-quality,
development and manufacturing of cannabis
API and derivative products

Genetics Selection

Genetics are the foundation of every product. GreenMed dedicates ample resources to select consistent, high-quality cannabis strains that ensure superior products.

Source Premium GACP Cultivators

We partner with selected local cultivators and monitor them through their growing process to bring out the finest premium harvest.

Low Temperature Closed Dry & Cure Process

For medical cannabis, the drying process is a crucial factor for the end-product. Our GMP Certified drying system can meet variable requirements by using special, customized drying techniques.

Supercritical CO2 Extraction Method

Ideal to produce pharmaceutical grade extracts with no residual solvent. Through this environmentally friendly and preferred method by the German pharmacopea, we provide consistent deliveries of high-quality concentrate while assuring a rising supply.

Product Development White Labeling

Through our extensive API selection, we are able to develop a wide range of innovative products.

R&D

The GreeenMed team is dedicated to developing new strains, processes and formulations to benefit our clients and expand market outreach.

Our Licenses & Certifications

Ministerio de Salud Pública
IRCCA
Good Agricultural Practice
Uruguay GMP
Europen Union GMP
in progress
MSB BPF ANVISA

Our Facility

Our Facility has been designed and built under
EU-GMP standards, using the finest technology,
and operated by an expert team of scientists,
researchers and pharmacists who take extreme care
for delivering safe, consistent and pure products


sqm

Total Production
Manufacturing Facility


tons

Annual Dry
& Cure capacity


tons

Annual Extraction
Processing capacity

1000
sqm

Finished Products
Storage Area

keep up to date

Receive company updates straight to your inbox.